Funding from the Bill & Melinda Gates Foundation will go toward understanding the benefits o novel cap analogs for therapeutic applications.Warsaw, December 8, 2022. ExPLoRNA Therapeutics, a Polish biotech company revolutionizing mRNA vaccines and therapeutics with unprecedented translational efficiency, received…
Join us at the world’s largest event for the biotech industry #2022 BIO International Convention in San Diego (June 13-16, 2022). Let’s discuss the impact of innovative RNA modification technology on therapeutics and vaccines development. With passion, ExploRNA Therapeutics develops ground-breaking innovations of mRNA as…
We’re pleased to invite you to an exclusive webinar with our CTO and Co-founder Dr. Joanna Kowalska. Watch to learn about “Harnessing the Chemical Modifications of 5' Cap to Boost mRNA Expression in Vivo”. The webinar is organized by Precision…
The Congress brings together the leading companies developing RNA-based therapeutics and is a global platform for advancing scientific and commercial collaborations, as well as sharing the recent advances and challenges of the field. Join Tomasz Piec, Board Member, and Piotr…